Credit Pete Comparoni | UK Photo.
Brooke Hudspeth, PharmD, is Chief Practice Officer (CPO) for the UK College of Pharmacy. Hudspeth, the acting secretary for the Kentucky Pharmacist Association (KphA) oversees all community pharmacy efforts for the college while working to elevate the care available to those in the Commonwealth.
Hudspeth is an alumnus of the college’s PharmD and Community Residency programs and serves as a preceptor for pharmacy students and residents. In addition, she is known for her collaboration with the American Pharmacists Association Foundation, The Kroger Co., and the Centers for Disease Control and Prevention (CDC) for her work on the National Diabetes Prevention Program (DPP). Hudspeth helped secure a $7.5M grant from the CDC to expand the National DPP to five states, using the model she developed for Kentucky.
Credit Pete Comparoni | UK Photo.
Brooke Hudspeth, PharmD, is Chief Practice Officer (CPO) for the UK College of Pharmacy. Hudspeth, the acting secretary for the Kentucky Pharmacist Association (KphA) oversees all community pharmacy efforts for the college while working to elevate the care available to those in the Commonwealth.
Hudspeth is an alumnus of the college’s PharmD and Community Residency programs and serves as a preceptor for pharmacy students and residents. In addition, she is known for her collaboration with the American Pharmacists Association Foundation, The Kroger Co., and the Centers for Disease Control and Prevention (CDC) for her work on the National Diabetes Prevention Program (DPP). Hudspeth helped secure a $7.5M grant from the CDC to expand the National DPP to five states, using the model she developed for Kentucky.
• Nov 11, 2020
The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S. Dr. Greg speaks with UK Director of Clinical Operations Linda Rice about the effort.
Listen
of
LEXINGTON, Ky. (Dec. 17, 2020) A new University of Kentucky study provides direct evidence for a testing strategy that could be used to support a shortened period of quarantine for university students who are exposed to the virus but are asymptomatic. The study is now available on the preprint server medRxiv and is pending journal review.
Working with UK Health Corps, researchers in the study enrolled 101 asymptomatic students in quarantine following COVID-19 exposure, and 90 students completed surveys and testing. Nasopharyngeal swabs for COVID-19 were given to the students on days three or four, five, seven, 10 and 14 of their quarantine.
Of the 90, 14 (16%) had at least one positive test while in quarantine, but no eligible students received an initial positive test on day 10 or 14. In this study, all eligible students who developed a COVID-19 infection were positive by day seven post-exposure.